Back to today’s briefing

Story perspectives

Hologic Targets Growth with Strategic Acquisitions in Oncology

8/31/2025

47 10

Summary

Story summary

Hologic aims to boost growth through mergers and acquisitions, focusing on oncology and breast health. Recent acquisitions include Biotheranostics and Endomagnetics.
The company's stock has a lower price-to-sales ratio compared to the industry average, with slight increases in earnings estimates.
Year-to-date, Hologic shares have fallen by 7.7%, outperforming the industry’s decline of 8.5%.

1 of 1

Story summary

Hologic aims to boost growth through mergers and acquisitions, focusing on oncology and breast health. Recent acquisitions include Biotheranostics and Endomagnetics.
The company's stock has a lower price-to-sales ratio compared to the industry average, with slight increases in earnings estimates.
Year-to-date, Hologic shares have fallen by 7.7%, outperforming the industry’s decline of 8.5%.